Table 3 Laboratory findings in the patient
From: Acute portal vein thrombosis secondary to COVID-19: a case report
Tests | Result | Reference |
|---|---|---|
C3 (mg/dL) | 130 | Adults: 90–180 |
C4 (mg/dL) | 29 | 100–40 |
LAC (s) | 40.8 | 28–42 |
Protein C (%) | 81 | 65–160 |
Protein S (%) | 89.8 | 65–150 |
Factor V Leiden (s) | 91.6 | ≥ 120 |
Anti-thrombin (%) | 123 | 70–140 |
ASMA | N | Up to 1:10 |
ANA (U/mL) | 7 | Negative: < 12 |
Borderline: 12–18 | ||
Positive: > 18 | ||
Anti-ds-DNA (U/mL) | 1.3 | Negative: < 12 |
Borderline: 12–18 | ||
Positive: > 18 | ||
β2 glyco-IgG (U/mL) | 52.8 | Negative: < 12 |
Equivocal: 12–18 | ||
Positive: > 18 | ||
β2 glyco-IgM (U/mL) | 2.4 | Negative: < 12 |
Equivocal: 12–18 | ||
Positive: > 18 |